This clinical research trial is evaluating an investigational oral medication designed to target a pathway involved in inflammation and pain signalling that is thought to contribute to migraines. The study aims to assess the safety and effectiveness of the investigational medication and identify the most appropriate dose for future research.
This study is being conducted at our Central Coast and Western Syndey and sites.
Apply Now
Paratus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326
